New York, New York--(Newsfile Corp. - February 9, 2021) - PCG Digital: Soligenix (NASDAQ: SNGX) continues to build excitement for its SGX301 candidate following strong Phase 3 data and commercialization plans. The company recently held an investor webcast to further explain the company's plans for commercializing its ground-breaking SGX301 candidate for the treatment of cutaneous T-cell lymphoma (CTCL).
Here are some key takeaways from the commercialization Q&A:
1. Soligenix will commercialize SGX301 in the U.S. on its own
During the presentation, the company noted that after conducting necessary due diligence and simulating different routes to commercialization, it was determined that a partnership would not be the best solution for shareholders. The licensing landscape and CTCL's small, orphan market were the key drivers behind the decision. Considering that the average biopharmaceutical licensing deal, a Phase 3 licensor will typically retain no more than 40% of the product's value, it did not make sense to give up so much value when the market is small and highly specialized to begin. However, Soligenix CEO Dr. Chris Schaber noted the company continues discussions regarding partnerships for ex-U.S. rights to SGX301.
The company has submitted its proposed brand name, HyBryte, and logo for SGX301 to the FDA for review and approval.
2. SGX301 marketing and sales force size and costs
CTCL's small, orphan market will not require Soligenix to build out a massive marketing and sales force. The uniqueness and ability to serve an unmet medical need are the key selling points in the CTCL treatment space. As a result, Soligenix estimates the need for a sales team consisting of around 20 people. The company estimates that pre-launch costs will come in around $7 million, with annual sales and marketing costs coming in below $10 million.
3. Ample cash reserves to carry SGX301 through commercialization
During the webcast, management was asked if the company's current cash reserves were sufficient enough to carry SGX301 through the commercialization process. After the previously-announced financing deal with Pontifax, the company continues to be well-capitalized for the commercialization process. It was revealed that the company currently maintains a cash balance of in excess of $20 million and also has a $20 million ATM with B. Riley.
Story continues
"Based on this strategic capital structure, we are well-positioned for success and really have no need for a large capital raise anytime soon," noted CFO Jonathan Guarino during the webcast.
4. Daavlin partnership for companion light device
On January 7, 2021, Soligenix first announced its strategic partnership with Daavlin, an Ohio-based company with a 40-year history in phototherapy. Daavlin has an extensive product line that is delivered to healthcare providers worldwide.
Under the strategic partnership, Daavlin will supply and distribute a commercially-ready companion light device that is critical to the success of SGX301 in treating CTCL. The companion light device is a derivative of an existing, 510K-approved product. Unlike other phototherapies, Daavlin's light device does not require a dedicated room or any complex wiring. In fact, the device can be stored and moved out of the way when not in use.
The Daavlin companion device will be sold directly to physicians initially, as treatments will be conducted in a doctor's office. However, Soligenix management notes that the company does intend to offer a house-use version of the Daavlin device down the road. However, it is important to note that Daavlin's UV devices are already approved for home use.
5. Soligenix estimates peak U.S. sales of SGX301 to hit $90 million
The pricing of SGX301 continues to be evaluated and will not be finalized until closer to the U.S. launch. However, management did note that an existing, inferior treatment, Valchor, was being considered as a benchmark price. Valchor's price is roughly $3,500 per WAC/tube and generates estimated annual sales of around $40 million.
Given the unique nature of SGX301 and its ability to serve as an early-stage treatment for CTCL, the company primary market research has shown that four out of five dermatologists are likely to prescribe the product, if/when approved. With Valchor as a benchmark, Soligenix estimates SGX301 will have peak U.S. net annual sales that exceed $90 million.
SGX301 Commercialization Timeline with Multiple Near Term Catalysts Anticipated
As SGX301 begins its commercialization phase, there will be several important milestones over the coming months that could serve to be significant catalysts for Soligenix. The first milestone to watch for will be the initial submission of the rolling New Drug Application (NDA). The NDA, along with the completed Clinical Study Report, is estimated to be handed over to the FDA during the second quarter of 2021.
Under the Prescription Drug User Fee Act, or PDUFA, the FDA is required to review new drug applications within a 10-month period. If the new drug has been given fast track designation, the FDA deadline to review the application is only six months.
SGX301 has already been granted fast track designation and orphan drug status. As a result, the FDA will have six months from the date that Soligenix officially files the NDA. Just as an example, this means that even if the NDA is filed at the end of June, a review will take place around the end of the year. The official U.S. commercial launch is estimated to occur during the second half of 2022.
Aside from the rolling NDA filing, resulting FDA review, and official commercial launch in 2022, investors will have a few other potential catalysts in the shorter-term. Soligenix announced that it has submitted abstracts to present on SGX301 to the American Academy of Dermatology Meeting in March 2021 and to the Society for Investigative Dermatology Meeting in May 2021. Management notes its plans to submit its manuscript to the JAMA Dermatology journal this year as well.
Zack's Research Updates Soligenix with a Positive Report
Two days after Soligenix's webcast, Zack's Small-Cap Research issued an updated research report on the company.
Zack's notes, that based on its probability-adjusted discounted cash flow (DCF) model (which estimates future revenues from SGX301, CiVax, etc.), there is significant potential price appreciation for SNGX.
"The webinar on SGX301 provided a comprehensive overview of the company's plans for commercializing SGX301, including encouraging data from primary market research with physicians and initial revenue projections. As discussed, there are a number of upcoming milestones for the company as it relates to SGX301, with perhaps the most important being the submission of the rolling NDA, which should begin in the second quarter of 2021."
The full report can be found here.
Disclaimer:
This communication was produced by PCG Digital Holdings, LLC, an affiliate of PCG Advisory Inc., (together "PCG"). PCG is an integrated investor relations, communications and strategic advisory firm. The information contained on this may be 'Paid Advertising' for purposes of Section 17(b) of the Securities Act of 1933, as amended (together with the rules and regulations there under, the "Securities Act"). PCG may be compensated by respective clients for publicizing information relating to its client's securities. For more information in terms of compensation received for services provided by PCG, see the pertinent advertising materials relating to the respective client. By accessing this Site and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy.
PCG is not a registered or licensed broker, dealer, broker-dealer, investment adviser nor investment manager, nor does PCG engage in any activities that would require such registrations. PCG does not provide investment advice, endorsement, analysis or recommendations with respect to any securities, and its services to or statements about its clients should never be construed as any endorsement of or opinion about any security of any client. No information contained in this communication constitutes an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other similar product or service regardless of whether such security, product, or service is referenced in this communication. Further, nothing in this communication is intended to provide tax, legal, or investment advice and nothing in this communication should be construed as a recommendation to buy, sell or hold any investment or security or to engage in any investment strategy or transaction. For full disclaimers, including compensation received for professional services, please visit http://www.pcgadvisory.com/disclosures.
Contact: info@pcgadvisory.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/73924
Follow this link:
Soligenix's Upcoming Catalysts Highlight Growth Potential as it Sheds Light on its Commercialization of SGX301 - Yahoo Finance
- Las Vegas author Lissa Townsend Rodgers sheds light on historic women in organized crime - Las Vegas Weekly - March 23rd, 2024 [March 23rd, 2024]
- Meta sheds more light on how it is evolving Llama 3 training it relies for now on almost 50000 Nvidia H100 GPU, but ... - TechRadar - March 23rd, 2024 [March 23rd, 2024]
- The Nigerian currency sheds off N500 against the US dollar - Business Insider Africa - March 23rd, 2024 [March 23rd, 2024]
- How the Princess of Wales' story sheds light on the importance of cancer screening - CBC.ca - March 23rd, 2024 [March 23rd, 2024]
- Library approved for storage shed thanks in-part to a $10000 donation from Friends of the Library - mykxlg.com - March 23rd, 2024 [March 23rd, 2024]
- Wake County students build sheds to help with nationwide demand - CBS17.com - March 23rd, 2024 [March 23rd, 2024]
- Quantum tornado sheds light on black holes - Innovation News Network - March 23rd, 2024 [March 23rd, 2024]
- Trent Brown sheds light on his decision to sign with Bengals in free agency - Stripe Hype - March 23rd, 2024 [March 23rd, 2024]
- Revealed: documents shed light on shadowy US far-right fraternal order - The Guardian US - March 23rd, 2024 [March 23rd, 2024]
- Fire destroys home and sheds in Troy | Local News | foxbangor.com - FOX Bangor/ABC 7 News and Stories - March 23rd, 2024 [March 23rd, 2024]
- Insider Sheds Light on Stefon Diggs Future With Bills After Cryptic Post - Heavy.com - March 23rd, 2024 [March 23rd, 2024]
- Sister Wives Star Garrison Brown's Sister Sheds Light on His Mental Health Struggles After Tragic Death - TooFab - March 23rd, 2024 [March 23rd, 2024]
- Synopsys (NASDAQ:SNPS) sheds 3.7% this week, as yearly returns fall more in line with earnings growth - Yahoo Finance - March 23rd, 2024 [March 23rd, 2024]
- Affidavit sheds light on charges against Tell City pastor - Eyewitness News (WEHT/WTVW) - March 23rd, 2024 [March 23rd, 2024]
- Gisele Bndchen Sheds Light on Life After Tom Brady's 2022 Divorce: The Only Time Something Is Fixed Is When You ... - EssentiallySports - March 23rd, 2024 [March 23rd, 2024]
- Toba Supereruption Sheds Light on Early Human Migration - Mirage News - March 23rd, 2024 [March 23rd, 2024]
- Miami Dolphins LB Anthony Walker Sheds New Light on Significant Health Scare - Pro Football Network - March 23rd, 2024 [March 23rd, 2024]
- Tyrese Haliburton sheds harsh truth on sports betting: I'm a prop - Sportskeeda - March 23rd, 2024 [March 23rd, 2024]
- The Daily Show Sheds Viewers with Co-Host Format - imdb - March 23rd, 2024 [March 23rd, 2024]
- French tax officials to hunt out undeclared sheds and verandas - The Connexion - March 23rd, 2024 [March 23rd, 2024]
- D'Angelo Russell sheds light on subtle disparity between sharing locker room with LeBron James & Kobe Bryant - Sportskeeda - March 14th, 2024 [March 14th, 2024]
- Steph Curry sheds light on his most savage trash-talking incident, eerily similar to Larry Bird's - Sportskeeda - March 14th, 2024 [March 14th, 2024]
- NOPD body cam footage sheds light on 'high-risk' arrest, use-of-force investigation - NOLA.com - March 14th, 2024 [March 14th, 2024]
- DEI-vestment: University of Florida sheds 'inclusion' for innovation Minding The Campus - Minding The Campus - March 14th, 2024 [March 14th, 2024]
- Bedford volleyball coach sheds light on investigation, leave of absence - Monroe Evening News - March 14th, 2024 [March 14th, 2024]
- Can World Hunger Be Eradicated by 2030? New Research Sheds Light on Key Puzzle Piece - SciTechDaily - March 14th, 2024 [March 14th, 2024]
- Alex Kurtzman Sheds Light on Star Trek Discovery's Tough Road to Season 5 - Den of Geek - March 14th, 2024 [March 14th, 2024]
- Is the iPhone SE 4 Worth the Wait? A New Report Sheds Light On it - Gizchina.com - March 14th, 2024 [March 14th, 2024]
- PEPE sheds 8% in 24 hours: Are investors losing confidence? - AMBCrypto News - March 14th, 2024 [March 14th, 2024]
- Fire moves from shed to house, damaging home in Cloquet - Northern News Now - March 14th, 2024 [March 14th, 2024]
- "COPA 71" documentary sheds light on forgotten Women's World Cup - Euronews - March 14th, 2024 [March 14th, 2024]
- Photo Series Sheds Light on Homelessness with Pets - Mirage News - March 14th, 2024 [March 14th, 2024]
- 'I thank the firefighters:' Neighbor on cars and shed catching fire in Bedford County - WSET - March 14th, 2024 [March 14th, 2024]
- New Study Sheds Light on Where India's People Came From - The Wire - March 14th, 2024 [March 14th, 2024]
- Who Was Behind Sam Altman's Ouster From OpenAI? New Reports Sheds A Light On Key Executives' Role - Micro - Benzinga - March 14th, 2024 [March 14th, 2024]
- Romanian stock indices start week in red, TTS sheds most - SeeNews - March 14th, 2024 [March 14th, 2024]
- XRPs gradual appreciation mystery: Ripple CTO sheds light on it - AMBCrypto News - March 14th, 2024 [March 14th, 2024]
- Are Edibles Safer Than Smoking? New Study Sheds Light on Cannabis and Heart Problems - Verywell Health - March 14th, 2024 [March 14th, 2024]
- New Protein Structure Sheds Light on Anti-Cancer Immunotherapies - Mirage News - March 14th, 2024 [March 14th, 2024]
- Whale menopause sheds light on human evolutionary mystery - The Borneo Post - March 14th, 2024 [March 14th, 2024]
- Podcast: In the Shed Ep 11 - BikePortland - February 7th, 2024 [February 7th, 2024]
- Sponsor spotlight: Winter-proof your space - The Original Mini Barns' guide to durable sheds and maintenance tips - My Edmonds News - February 7th, 2024 [February 7th, 2024]
- RTX 4080 Super teardown sheds light on power connector controversy PCB shows traces for two 8-pin connectors ... - Tom's Hardware - February 7th, 2024 [February 7th, 2024]
- Israeli-American activist Peled sheds light on decades of terror in Palestine - Middle East Monitor - February 7th, 2024 [February 7th, 2024]
- Research sheds insight on replacement heifers - Beef Magazine - February 7th, 2024 [February 7th, 2024]
- Being a YouTuber Musician is Way More Expensive Than You Think: Guitarist Sheds Light on Costs of Online Career - Ultimate Guitar - February 7th, 2024 [February 7th, 2024]
- CDC Sheds Light on High HIV Risk Among Trans Women - POZ - February 7th, 2024 [February 7th, 2024]
- Metal shed cave in kills one, injures several others - China Daily - February 7th, 2024 [February 7th, 2024]
- Former island resident sheds light on Middle East crisis - Kodiak Daily Mirror - February 7th, 2024 [February 7th, 2024]
- Home Items You Really Shouldn't Be Storing In An Outdoor Shed - House Digest - February 7th, 2024 [February 7th, 2024]
- 'Where is Wendy Williams?' Documentary Trailer Sheds Light on Icon's Personal Struggles - Just Jared - February 7th, 2024 [February 7th, 2024]
- Cha Eun Woo sheds a tear in 'Entity' concept film & photos - allkpop - February 7th, 2024 [February 7th, 2024]
- Fire damages 6 vehicles, 1 shed in Tornillo - KTSM 9 News - February 7th, 2024 [February 7th, 2024]
- National survey sheds new light on outdoor participation - Newton County Times - February 7th, 2024 [February 7th, 2024]
- Research Sheds New Light on Origin of Syphilis, Rescues Columbus' Reputation - Science & Health - Haaretz - February 7th, 2024 [February 7th, 2024]
- Insider Sheds Light On Recent Chicago Bears-Washington Trade Rumors - Sports Mockery - February 7th, 2024 [February 7th, 2024]
- Kelly Clarkson Sheds Light on the Health Diagnosis That Kickstarted Her Weight Loss - Parade Magazine - February 7th, 2024 [February 7th, 2024]
- MAFS star sheds light on extreme wedding day filming: 'Everyone's really wasted' - Yahoo Lifestyle Australia - February 7th, 2024 [February 7th, 2024]
- L.A Coliseum Controversy Silenced as NASCAR Insider Sheds Light on Severity of the Storm - EssentiallySports - February 7th, 2024 [February 7th, 2024]
- Transient accused of starting fire in shed by Sunnyside Museum - Yakima Herald-Republic - February 7th, 2024 [February 7th, 2024]
- Police report sheds light on Redmond man's death from cold exposure after crash, fall on rocks above Dry Canyon - KTVZ - January 22nd, 2024 [January 22nd, 2024]
- DC sheds light on 'House of Brainiacs' Superman crossover in April 2024 AIPT - AIPT - January 22nd, 2024 [January 22nd, 2024]
- Eviction filing sheds light on 5-year-olds deadly fall from KC apartment - WDAF FOX4 Kansas City - January 22nd, 2024 [January 22nd, 2024]
- 'She adored Harry' Robert Hardman sheds light on The Queen's 'special relationship' with grandson - GB News - January 22nd, 2024 [January 22nd, 2024]
- Cam Newton sheds light on Justin Fields' late hits with eye-opening, personal anecdote - NBC Sports Chicago - January 22nd, 2024 [January 22nd, 2024]
- Research sheds new light on moon rock formation solving major puzzle in lunar geology - Phys.org - January 22nd, 2024 [January 22nd, 2024]
- Novel mineral sheds light on rare-earth formation - China Daily - January 22nd, 2024 [January 22nd, 2024]
- Tangoe's Analysis Sheds Light on Taming Cloud Costs in 2024 - Techiexpert.com - TechiExpert.com - January 22nd, 2024 [January 22nd, 2024]
- Controversial F-Factor diet creator sheds uptown condo for $24 million - Crain's New York Business - January 22nd, 2024 [January 22nd, 2024]
- Tesla market valuation sheds $94 billion in first weeks of 2024 - CBT Automotive News - January 22nd, 2024 [January 22nd, 2024]
- Aryna Sabalenka Sheds Light on New Superstitious 'Routine' with Her Physiotherapist -'Anything for the Win' - EssentiallySports - January 22nd, 2024 [January 22nd, 2024]
- 'He Didn't Have the Courage' - Novak Djokovic Sheds Light on Ill-Tempered Interaction With Heckler at Australian Open - EssentiallySports - January 22nd, 2024 [January 22nd, 2024]
- Milwaukee Bucks' Adrian Griffin Sheds Light On Giannis Antetokounmpo's Sudden Injury Absence Vs. Cavs - Wisconsin Sports Heroics - January 22nd, 2024 [January 22nd, 2024]
- At the End of This Once-Barren Yard Is a Shed That's Now a Cozy Hideaway - Domino - January 22nd, 2024 [January 22nd, 2024]
- San Antonio shed fire spreads, causing $100,000 damage: Space heater suspected - FOX 29 - January 22nd, 2024 [January 22nd, 2024]
- Body found following shed fire | Community - The Leader News - January 22nd, 2024 [January 22nd, 2024]
- A Royal Expert Sheds Light on Why Kate Middleton and King Charles' Surgeries Were Announced on the Same Day - Yahoo Lifestyle Australia - January 22nd, 2024 [January 22nd, 2024]
- Tribune-Star Editorial: CANDLES again sheds light on darkness of hate speech - Terre Haute Tribune Star - August 20th, 2022 [August 20th, 2022]
- Digital mortgage firm Blend loses $478M, sheds more of workforce - The Real Deal - August 20th, 2022 [August 20th, 2022]
- Interview Sheds Light On Toyotas Thinking About EVs - CleanTechnica - August 20th, 2022 [August 20th, 2022]